RedHill Biopharma Statistics
Total Valuation
RDHL has a market cap or net worth of $3.27 million. The enterprise value is -$3.38 million.
Important Dates
The next estimated earnings date is Friday, April 11, 2025, before market open.
| Earnings Date | Apr 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RDHL has 1.28 million shares outstanding. The number of shares has increased by 697.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.28M |
| Shares Change (YoY) | +697.64% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | 3.33% |
| Float | 1.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| Forward PS | n/a |
| PB Ratio | 51.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 9.15.
| Current Ratio | 0.74 |
| Quick Ratio | 0.39 |
| Debt / Equity | 9.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,708.61% and return on invested capital (ROIC) is -401.79%.
| Return on Equity (ROE) | -1,708.61% |
| Return on Assets (ROA) | -44.88% |
| Return on Invested Capital (ROIC) | -401.79% |
| Return on Capital Employed (ROCE) | -2,590.14% |
| Revenue Per Employee | $69,943 |
| Profits Per Employee | -$569,321 |
| Employee Count | 53 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.53% in the last 52 weeks. The beta is 3.83, so RDHL's price volatility has been higher than the market average.
| Beta (5Y) | 3.83 |
| 52-Week Price Change | -80.53% |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 7.53 |
| Relative Strength Index (RSI) | 28.76 |
| Average Volume (20 Days) | 121,911 |
Short Selling Information
| Short Interest | 46,646 |
| Short Previous Month | 33,975 |
| Short % of Shares Out | 4.11% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, RDHL had revenue of $3.71 million and -$30.17 million in losses. Loss per share was -$38.52.
| Revenue | 3.71M |
| Gross Profit | 1.26M |
| Operating Income | -20.49M |
| Pretax Income | 23.92M |
| Net Income | -30.17M |
| EBITDA | -20.94M |
| EBIT | -20.49M |
| Loss Per Share | -$38.52 |
Full Income StatementBalance Sheet
The company has $7.28 million in cash and $558,000 in debt, giving a net cash position of $6.72 million or $5.25 per share.
| Cash & Cash Equivalents | 7.28M |
| Total Debt | 558,000 |
| Net Cash | 6.72M |
| Net Cash Per Share | $5.25 |
| Equity (Book Value) | 61,000 |
| Book Value Per Share | 0.05 |
| Working Capital | -5.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.23 million and capital expenditures -$5,000, giving a free cash flow of -$24.24 million.
| Operating Cash Flow | -24.23M |
| Capital Expenditures | -5,000 |
| Free Cash Flow | -24.24M |
| FCF Per Share | -$18.93 |
Full Cash Flow StatementMargins
| Gross Margin | 34.04% |
| Operating Margin | -552.68% |
| Pretax Margin | -813.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |